Ampio Pharmaceuticals Inc (AMPE)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

373 INVERNESS PARKWAY ENGLEWOOD, CO 80112

Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which are now starting clinical trials, and new molecular entities ("NMEs"). A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize the company's product development programs.

Data as of 2020-09-12
Market Cap132.053 Million Shares Outstanding176.542 Million Avg 30-day Volume2.673 Million
P/E Ratio Dividend Yield EPS-0.15
Price/Sales Price cash flow ratio Price free cash flow ratio-6.7
Book Value0.04 Price to Tangible Book19.76 Alpha0.03
Short Interest Ratio6.62 % Short Interest to Float9.0 R-squared0.041157
BETA1.9263 52-week High/Low1.24 / 0.26 Stddev0.405707
View SEC Filings from AMPE instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 78 77 1.3% 5 (0.33%) 5 (0.32%) 0.0%
13F shares: 17.476 Million 16.442 Million 6.29% 1.008 Million 1.062 Million -5.11%
% Ownership 9.8989 10.0904 -1.9% 0.571 0.652 -12.42%
New Positions: 10 13 -23.08%
Increased Positions 22 17 29.41% 2 2 0.0%
Closed Positions 6 11 -45.45% 5
Reduced Positions 10 11 -9.09% 2
Total Calls 570.563 Thousand 528.701 Thousand 7.92% 50.9 Thousand 47.2 Thousand 7.84%
Total Puts 143.544 Thousand 120.529 Thousand 19.09% 47.1 Thousand 35.9 Thousand 31.2%
PUT/CALL Ratio 0.25 0.23 8.7% 0.93 0.76 22.37%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AMPE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AMPE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COELHO PHILIP H

0 2020-07-01 3

GILES RICHARD B

0 2020-07-01 3

MACALUSO MICHAEL CEO

0 2020-07-01 2

BAR-OR DAVID

0 2020-07-01 5

STEVENS DAVID R

121,049 2020-01-02 2

STOKELY DAN CFO

0 2020-01-02 1

CHEREVKA HOLLI CHIEF OPERATING OFFICER

0 2019-09-16 0

CHILCOTT, III THOMAS E. CHIEF FINANCIAL OFFICER

  • Officer
0 2018-10-01 0

GOULD GREGORY A CHIEF FINANCIAL OFFICER

  • Officer
0 2016-07-15 0

CLIFT VAUGHAN LENNOX CHIEF REGULATORY AFFAIRS

  • Officer
0 2015-07-31 0

MCGREGOR MARK D CHIEF FINANCIAL OFFICER

  • Officer
0 2013-11-08 0

DISBROW JOSHUA R. CHIEF OPERATING OFFICER

  • Officer
0 2012-12-15 0

WINGERTER DONALD B JR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
325,000 2011-05-18 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments